Team:Peking/Safety
From 2013.igem.org
XingjiePan (Talk | contribs) |
|||
(51 intermediate revisions not shown) | |||
Line 130: | Line 130: | ||
#navigationblock{background-color:#fafaf8; position:fixed; top:0px; width:1200px; height:130px; overflow:hidden; font-family:Calibri, Arial; float:left; margin:0px; padding:0px; z-index:1000; border-bottom:1px solid #d3d7d8;} | #navigationblock{background-color:#fafaf8; position:fixed; top:0px; width:1200px; height:130px; overflow:hidden; font-family:Calibri, Arial; float:left; margin:0px; padding:0px; z-index:1000; border-bottom:1px solid #d3d7d8;} | ||
- | #navbarlogo{position: | + | #navbarlogo{position:absolute; top:0px; left:0px; width:1200px} |
- | #navigationbar{position:absolute; left: | + | #navigationbar{position:absolute; left:460px; top:38px; font-size:16px; font-weight:100; color:black;} |
- | #navigationbar > li {display:block; list-style-type:none; float:left; width: | + | #navigationbar > li {display:block; list-style-type:none; float:left; width:75px; height:30px; text-align:center; } |
+ | .Navbar_Item{background-color:transparent;} | ||
.Navbar_Item a {color:black; text-decoration:none;} | .Navbar_Item a {color:black; text-decoration:none;} | ||
- | .Navbar_Item > ul {display:none; width: | + | .Navbar_Item > ul {display:none; width:900px; height:80px; text-align:center; color:black; z-index:1100; } |
- | .Navbar_Item > ul > li {float:left; list-style:none | + | .Navbar_Item > ul > li {float:left; list-style:none; text-align:center; background-color:transparent; position:relative; top:10px; padding:0 10px;} |
- | .Navbar_Item:hover{ border-bottom:1px solid #D00000; color:#D00000} | + | .Navbar_Item:hover{ border-bottom:1px solid #D00000; color:#D00000; background-color:#fafaf8;} |
- | .Navbar_Item:hover > ul{ display:block;} | + | .Navbar_Item:hover > ul{zoom:1; display:block;} |
- | .Navbar_Item:hover >a {color:#D00000} | + | .Navbar_Item:hover >a {color:#D00000; background-color:#fafaf8;} |
- | .Navbar_Item > ul > li:hover {border-bottom:1px solid #D00000; color:#D00000} | + | .Navbar_Item > ul > li:hover {border-bottom:1px solid #D00000; color:#D00000; background-color:#fafaf8;} |
.Navbar_Item > ul > li:hover >a {color:#D00000} | .Navbar_Item > ul > li:hover >a {color:#D00000} | ||
+ | .BackgroundofSublist{position:absolute; left:-1000px; width:2000px; height:80px; background-color:#ffffff; opacity:0;} | ||
#Home_Sublist{position:relative; top:0px; left:-50px;} | #Home_Sublist{position:relative; top:0px; left:-50px;} | ||
- | #Team_Sublist{position:relative; top:0px; left:- | + | #Team_Sublist{position:relative; top:0px; left:-110px;} |
- | #Project_Sublist{position:relative; top:0px; left:- | + | #Project_Sublist{position:relative; top:0px; left:-180px;} |
#Model_Sublist{position:relative; top:0px; left:-140px;} | #Model_Sublist{position:relative; top:0px; left:-140px;} | ||
+ | #DataPage_Sublist{position:relative; top:0px; left:-60px;} | ||
#Safety_Sublist{position:relative; top:0px; left:-180px;} | #Safety_Sublist{position:relative; top:0px; left:-180px;} | ||
- | #HumanPractice_Sublist{position:relative; top:0px; left:- | + | #HumanPractice_Sublist{position:relative; top:0px; left:-470px;} |
- | #iGEM_logo{position: | + | #iGEM_logo{position:absolute; top:30px; left:1090px; height:80px;} |
/*end navigation bar*/ | /*end navigation bar*/ | ||
/*Major body*/ | /*Major body*/ | ||
#MajorBody{position:absolute; top:0px; left:0px; width:1200px; height:1019px;} | #MajorBody{position:absolute; top:0px; left:0px; width:1200px; height:1019px;} | ||
- | #ProjectTitle{position:absolute; left:200px; background-color:# | + | #ProjectTitle{position:absolute; left:200px; background-color:#00303e; width:1000px; height:210px; top:150px; z-index:600;} |
#ProjectName{text-align:center; position:absolute; width:1000px; left:0px; top:40px; border-bottom:0px; color:#FFFFFF; font-size:45px; font-family:calibri,Arial, Helvetica, sans-serif;} | #ProjectName{text-align:center; position:absolute; width:1000px; left:0px; top:40px; border-bottom:0px; color:#FFFFFF; font-size:45px; font-family:calibri,Arial, Helvetica, sans-serif;} | ||
#ProjectSubname{text-align:center; position:absolute; width:1000px; left:0px; top:130px; border-bottom:0px; color:#FFFFFF; font-size:19px; font-family:calibri, Arial, Helvetica, sans-serif;} | #ProjectSubname{text-align:center; position:absolute; width:1000px; left:0px; top:130px; border-bottom:0px; color:#FFFFFF; font-size:19px; font-family:calibri, Arial, Helvetica, sans-serif;} | ||
#LeftNavigation{position:fixed; top:130px; float:left; width:200px; height:100%; background-color:#313131; z-index:900;} | #LeftNavigation{position:fixed; top:130px; float:left; width:200px; height:100%; background-color:#313131; z-index:900;} | ||
- | # | + | #SafetyListTitle{position:absolute; top:50px; left:30px; color:#ffffff; font-size:30px; font-family: calibri, arial, helvetica, sans-serif; text-decoration:none; border-bottom:0px;} |
- | # | + | #SafetyList{position:absolute; top:110px; left:15px; color:#ffffff; font-family: calibri, arial, helvetica, sans-serif;} |
- | # | + | #SafetyList > li {display:block; list-style-type:none; width:100px; height:25px; font-size:18px; text-align:left; background-color:transparent;} |
- | + | .SensorsListItem>a {color:#ffffff; text-decoration:none;} | |
+ | .SensorsListItem:hover >a{color:#999999;} | ||
- | # | + | #SafetyEditingArea{position:absolute; left:200px; top:360px; height:2000px; width:1000px; background-color:#ffffff;} |
Line 176: | Line 180: | ||
/*end of Major body*/ | /*end of Major body*/ | ||
- | /* | + | /*SafetyEditingArea*/ |
#PageTitle{text-align:center; position:absolute; top:40px; left:0px; width:1000px; border-bottom:0px ; color:#535353; font-weight:bold ;font-size:35px;font-family:calibri,arial,helvetica,sans-serif;} | #PageTitle{text-align:center; position:absolute; top:40px; left:0px; width:1000px; border-bottom:0px ; color:#535353; font-weight:bold ;font-size:35px;font-family:calibri,arial,helvetica,sans-serif;} | ||
Line 188: | Line 192: | ||
#ContentSafety2{line-height:25px;text-align:justify; position:absolute; top:1060px ; left:80px; width:840px; border-bottom:0px; color:#1b1b1b; font-size:18px;font-family:calibri,arial,helvetica,sans-serif;} | #ContentSafety2{line-height:25px;text-align:justify; position:absolute; top:1060px ; left:80px; width:840px; border-bottom:0px; color:#1b1b1b; font-size:18px;font-family:calibri,arial,helvetica,sans-serif;} | ||
#ContentSafety3{line-height:25px;text-align:justify; position:absolute; top:1340px ; left:80px; width:840px; border-bottom:0px; color:#1b1b1b; font-size:18px;font-family:calibri,arial,helvetica,sans-serif;} | #ContentSafety3{line-height:25px;text-align:justify; position:absolute; top:1340px ; left:80px; width:840px; border-bottom:0px; color:#1b1b1b; font-size:18px;font-family:calibri,arial,helvetica,sans-serif;} | ||
- | #ContentSafety4{line-height:25px;text-align:justify; position:absolute; top: | + | #ContentSafety4{line-height:25px;text-align:justify; position:absolute; top:1730px ; left:80px; width:840px; border-bottom:0px; color:#1b1b1b; font-size:18px;font-family:calibri,arial,helvetica,sans-serif;} |
- | #Question1{font-style:Italic; font-weight:Bold; line-height: | + | #Question1{font-style:Italic; font-weight:Bold; line-height:30px; text-align:justify; position:absolute; top:95px ; left:100px; width:800px; border-bottom:0px; color:#00303e; font-size:18px;font-family:calibri,arial,helvetica,sans-serif;} |
- | #Question2{font-style:Italic; font-weight:Bold; line-height: | + | #Question2{font-style:Italic; font-weight:Bold; line-height:30px; text-align:justify; position:absolute; top:910px ; left:100px; width:800px; border-bottom:0px; color:#00303e; font-size:18px;font-family:calibri,arial,helvetica,sans-serif;} |
- | #Question3{font-style:Italic; font-weight:Bold; line-height: | + | #Question3{font-style:Italic; font-weight:Bold; line-height:30px; text-align:justify; position:absolute; top:1218px ; left:100px; width:800px; border-bottom:0px; color:#00303e; font-size:18px;font-family:calibri,arial,helvetica,sans-serif;} |
- | #Question4{font-style:Italic; font-weight:Bold; line-height: | + | #Question4{font-style:Italic; font-weight:Bold; line-height:30px; text-align:justify; position:absolute; top:1580px ; left:100px; width:650px; border-bottom:0px; color:#00303e; font-size:18px;font-family:calibri,arial,helvetica,sans-serif;} |
+ | #Safetydiv1{position:absolute; top:831px; width:1000px; height:289px; background-color:#f9f9f9} | ||
+ | #Safetydiv2{position:absolute; top:1470px; width:1000px; height:400px; background-color:#f9f9f9} | ||
+ | #SafetyFigure1{position:absolute; top:350px; height:250px; left:100px} | ||
- | # | + | #MileStone1{position:absolute; top:-100px;} |
+ | #MileStone2{position:absolute; top:690px;} | ||
+ | #MileStone3{position:absolute; top:1020px;} | ||
+ | #MileStone4{position:absolute; top:1380px;} | ||
Line 208: | Line 218: | ||
<div id="navigationblock"> | <div id="navigationblock"> | ||
<img id="navbarlogo" src="https://static.igem.org/mediawiki/igem.org/c/c9/Peking_Logo.jpg"/> | <img id="navbarlogo" src="https://static.igem.org/mediawiki/igem.org/c/c9/Peking_Logo.jpg"/> | ||
+ | |||
<ul id="navigationbar"> | <ul id="navigationbar"> | ||
<li id="PKU_navbar_Home" class="Navbar_Item"> | <li id="PKU_navbar_Home" class="Navbar_Item"> | ||
- | <a href="https://2013.igem.org/Team:Peking"> | + | |
+ | <a href="https://2013.igem.org/Team:Peking">Home</a> | ||
<ul id="Home_Sublist" > | <ul id="Home_Sublist" > | ||
- | |||
- | |||
- | |||
</ul> | </ul> | ||
</li> | </li> | ||
<li id="PKU_navbar_Team" class="Navbar_Item"> | <li id="PKU_navbar_Team" class="Navbar_Item"> | ||
- | <a href=" | + | <a href="">Team</a> |
<ul id="Team_Sublist"> | <ul id="Team_Sublist"> | ||
- | <li><a> | + | <div class="BackgroundofSublist"></div> |
- | <li><a> | + | <li><a href="https://2013.igem.org/Team:Peking/Team/Members">Members</a></li> |
- | <li><a> | + | <li><a href="https://2013.igem.org/Team:Peking/Team/Notebook">Notebook</a></li> |
+ | <li><a href="https://2013.igem.org/Team:Peking/Team/Attributions">Attributions</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
<li id="PKU_navbar_Project" class="Navbar_Item"> | <li id="PKU_navbar_Project" class="Navbar_Item"> | ||
- | <a href="https://2013.igem.org/Team:Peking/Project"> | + | <a href="https://2013.igem.org/Team:Peking/Project">Project</a> |
<ul id="Project_Sublist"> | <ul id="Project_Sublist"> | ||
- | <li><a> | + | <div class="BackgroundofSublist"></div> |
- | <li><a> | + | <li><a href="https://2013.igem.org/Team:Peking/Project/SensorMining">Biosensor Mining</a></li> |
- | <li><a>Band-pass | + | <li><a href="https://2013.igem.org/Team:Peking/Project/BioSensors">Biosensors</a></li> |
- | <li><a> | + | <li><a href="https://2013.igem.org/Team:Peking/Project/Plugins">Adaptors</a></li> |
+ | <li><a href="https://2013.igem.org/Team:Peking/Project/BandpassFilter">Band-pass Filter</a></li> | ||
+ | <li><a href="https://2013.igem.org/Team:Peking/Project/Devices">Devices</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
<li id="PKU_navbar_Model" class="Navbar_Item"> | <li id="PKU_navbar_Model" class="Navbar_Item"> | ||
- | <a href=" | + | <a href="">Model</a> |
<ul id="Model_Sublist"> | <ul id="Model_Sublist"> | ||
- | + | <div class="BackgroundofSublist"></div> | |
- | + | <li><a href="https://2013.igem.org/Team:Peking/Model">Band-pass Filter</a></li> | |
- | <li><a> | + | <li><a href="https://2013.igem.org/Team:Peking/ModelforFinetuning">Biosensor Fine-tuning</a></li> |
+ | </ul> | ||
+ | </li> | ||
+ | <li id="PKU_navbar_HumanPractice" class="Navbar_Item" style="width:90px"> | ||
+ | <a href="">Data page</a> | ||
+ | <ul id="DataPage_Sublist"> | ||
+ | <div class="BackgroundofSublist"></div> | ||
+ | <li><a href="https://2013.igem.org/Team:Peking/DataPage/Parts">Parts</a></li> | ||
+ | <li><a href="https://2013.igem.org/Team:Peking/DataPage/JudgingCriteria">Judging Criteria</a></li> | ||
+ | |||
</ul> | </ul> | ||
</li> | </li> | ||
<li id="PKU_navbar_Safety" class="Navbar_Item"> | <li id="PKU_navbar_Safety" class="Navbar_Item"> | ||
- | <a href="https://2013.igem.org/Team:Peking/Safety"> | + | <a href="https://2013.igem.org/Team:Peking/Safety">Safety</a> |
<ul id="Safety_Sublist"> | <ul id="Safety_Sublist"> | ||
- | |||
- | |||
- | |||
</ul> | </ul> | ||
</li> | </li> | ||
<li id="PKU_navbar_HumanPractice" class="Navbar_Item" style="width:120px"> | <li id="PKU_navbar_HumanPractice" class="Navbar_Item" style="width:120px"> | ||
- | <a href="https://2013.igem.org/Team:Peking/HumanPractice"> | + | <a href="https://2013.igem.org/Team:Peking/HumanPractice">Human Practice</a> |
- | <ul id="HumanPractice_Sublist"> | + | <ul id="HumanPractice_Sublist"> |
- | + | <div class="BackgroundofSublist"></div> | |
- | <li><a> | + | <li><a href="https://2013.igem.org/Team:Peking/HumanPractice/Questionnaire">Questionnaire Survey</a></li> |
- | <li><a> | + | <li><a href="https://2013.igem.org/Team:Peking/HumanPractice/FactoryVisit">Visit and Interview</a></li> |
+ | <li><a href="https://2013.igem.org/Team:Peking/HumanPractice/ModeliGEM">Practical Analysis</a></li> | ||
+ | <li><a href="https://2013.igem.org/Team:Peking/HumanPractice/iGEMWorkshop">Team Communication</a></li> | ||
+ | |||
</ul> | </ul> | ||
</li> | </li> | ||
</ul> | </ul> | ||
- | <a href="https://igem.org/ | + | <a href="https://2013.igem.org/Main_Page"><img id="iGEM_logo" src="https://static.igem.org/mediawiki/igem.org/4/48/Peking_igemlogo.jpg"/></a> |
</div> | </div> | ||
<!--end navigationbar--> | <!--end navigationbar--> | ||
- | |||
<!--MajorBody--> | <!--MajorBody--> | ||
<div id="MajorBody"> | <div id="MajorBody"> | ||
Line 273: | Line 293: | ||
<div id="LeftNavigation"> | <div id="LeftNavigation"> | ||
- | <h1 id=" | + | <h1 id="SafetyListTitle">Safety</h1> |
- | <ul id=" | + | <ul id="SafetyList"> |
- | + | <li class="SensorsListItem"><a href="#MileStone1">Research safety</a><li> | |
- | + | <li class="SensorsListItem"><a href="#MileStone2">Biobrick safety</a><li> | |
- | + | <li class="SensorsListItem"><a href="#MileStone3">Safety supervision</a><li> | |
- | + | <li class="SensorsListItem"><a href="#MileStone4">Safety suggestions</a><li> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
</ul> | </ul> | ||
</div> | </div> | ||
- | <div id=" | + | <div id="SafetyEditingArea"> |
+ | <div id="Safetydiv1"></div> | ||
+ | <div id="Safetydiv2"></div> | ||
<div > | <div > | ||
- | <h1 id="QuestionTitle1"> | + | <h1 id="QuestionTitle1"> Question1 </h1> |
<h2 id="QuestionTitle2"> Question2 </h2> | <h2 id="QuestionTitle2"> Question2 </h2> | ||
<h3 id="QuestionTitle3"> Question3 </h3> | <h3 id="QuestionTitle3"> Question3 </h3> | ||
Line 297: | Line 314: | ||
<p id="Question1"> | <p id="Question1"> | ||
Would any of your project ideas raise safety issues in terms of: | Would any of your project ideas raise safety issues in terms of: | ||
- | <br/> | + | <br/>§ researcher safety, |
- | <br/> | + | <br/>§ public safety, or |
- | <br/> | + | <br/>§ environmental safety |
</p> | </p> | ||
<p id="Question2"> | <p id="Question2"> | ||
Do any of the new BioBrick parts (or devices) that you made this year raise safety issues? If yes, | Do any of the new BioBrick parts (or devices) that you made this year raise safety issues? If yes, | ||
- | <br/> | + | <br/>§ Did you document these issues in the Registry? |
- | <br/> | + | <br/>§ How did you manage to handle the safety issue? |
- | <br/> | + | <br/>§ How could other teams learn from your experience? |
</p> | </p> | ||
<p id="Question3"> | <p id="Question3"> | ||
Is there a local biosafety group, committee, or review board at your institution? | Is there a local biosafety group, committee, or review board at your institution? | ||
- | <br/> | + | <br/>§ If yes, what does your local biosafety group think about your project? |
- | <br/> | + | <br/>§ If no, which specific biosafety rules or guidelines do you have to consider in your country? |
</p> | </p> | ||
<p id="Question4"> | <p id="Question4"> | ||
- | Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering? | + | § Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? <br/> |
+ | § How could parts, devices and systems be made even safer through biosafety engineering? | ||
</p> | </p> | ||
<p id="ContentSafety1"> | <p id="ContentSafety1"> | ||
- | The only organisms we worked with are Escherichia coli | + | The only organisms we worked with are <I>Escherichia coli K12</I> and <I>Pseudomonas Putida MT2</I>, both of which are considered lab-safe. The main dangerous elements in this project are the target aromatic chemicals. The risks these aromatic compounds pose are precisely the reason that we are working with them. We took careful steps to protect ourselves while working with them in the lab. |
<br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/> | <br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/> | ||
- | Members who were working directly with these compounds wore | + | Members who were working directly with these compounds wore organic vapor respirators for protection against inhalation. In addition to masks, lab members also wore lab coats and gloves to protect against absorption into the skin. After use, these compounds were disposed of by sending them off to the College of Chemistry for appropriate handling. |
- | <br/>Containment is not a problem. If our E. coli or parts leaked into the environment, we do not foresee bacteria that fluoresce upon exposure to toxic aromatic compounds being an environmental or health hazard. Our parts would be very difficult to maliciously misuse, unless the intent is to maliciously detect compounds. | + | <br/>Containment is not a problem. If our <I>E. coli</I> or parts leaked into the environment, we do not foresee bacteria that fluoresce upon exposure to toxic aromatic compounds being an environmental or health hazard. Our parts would be very difficult to maliciously misuse, unless the intent is to maliciously detect compounds. |
</p> | </p> | ||
Line 340: | Line 358: | ||
+ | <img id="SafetyFigure1" src="https://static.igem.org/mediawiki/igem.org/c/c0/Peking2013_SaftyFigure1_ZYH.jpg" /> | ||
- | + | <div id="MileStone1"></div> | |
+ | <div id="MileStone2"></div> | ||
+ | <div id="MileStone3"></div> | ||
+ | <div id="MileStone4"></div> | ||
Latest revision as of 18:18, 28 October 2013
Safety
Are We Biosafe Enough?
Question1
Question2
Question3
Question4
Would any of your project ideas raise safety issues in terms of:
§ researcher safety,
§ public safety, or
§ environmental safety
Do any of the new BioBrick parts (or devices) that you made this year raise safety issues? If yes,
§ Did you document these issues in the Registry?
§ How did you manage to handle the safety issue?
§ How could other teams learn from your experience?
Is there a local biosafety group, committee, or review board at your institution?
§ If yes, what does your local biosafety group think about your project?
§ If no, which specific biosafety rules or guidelines do you have to consider in your country?
§ Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions?
§ How could parts, devices and systems be made even safer through biosafety engineering?
The only organisms we worked with are Escherichia coli K12 and Pseudomonas Putida MT2, both of which are considered lab-safe. The main dangerous elements in this project are the target aromatic chemicals. The risks these aromatic compounds pose are precisely the reason that we are working with them. We took careful steps to protect ourselves while working with them in the lab.
Members who were working directly with these compounds wore organic vapor respirators for protection against inhalation. In addition to masks, lab members also wore lab coats and gloves to protect against absorption into the skin. After use, these compounds were disposed of by sending them off to the College of Chemistry for appropriate handling.
Containment is not a problem. If our E. coli or parts leaked into the environment, we do not foresee bacteria that fluoresce upon exposure to toxic aromatic compounds being an environmental or health hazard. Our parts would be very difficult to maliciously misuse, unless the intent is to maliciously detect compounds.
Our BioBrick parts do not pose any safety issues.
The 2013 Peking iGEM team complies with all the rules set forth by The Office of Laboratory and Equipment of Peking University strictly. We did not have direct contact with the office, however our project was closely monitored by team advisors and instructors, who ensured that laboratory risks were kept at a minimum.
A mandatory biosafety education video or brief class for all iGEM teammates, including a mechanism to ensure that all teammates involved in wet lab work complete the class, for example a verification code supplied upon completion that needs to be submitted by all team members in order for an iGEM team to be able to register for the jamboree. Having better-informed scientists is the best and fastest way to a safer competition.